30 closest matches · ranked by relevance
Colorectal Cancer
Primary: Proportion of Subjects Who Completed Colorectal Cancer (CRC) Screening Within 6 Months (Trial - Age Group 50-75) — 598; 192 Participants
Colorectal Cancer
Primary: Percent of Patients Receiving GI Consult for FOBT+ Results — 39; 47; 64; 51 percent patients receiving GI consult
Colorectal Cancer
Primary: Colorectal Cancer Screening Participation, Defined as Completion of a Guaiac or Immunochemical Stool Occult Blood Test, Colonoscopy, Sigmoidoscopy, or Barium Enem…
Colorectal Cancer · Screening
Primary: Colorectal Cancer Stage (pTNM) — 46; 85 Participants
Colorectal Neoplasms
Primary: Colorectal Cancer Screening — 127; 112 participants — p=0.01
Colorectal Neoplasms · Digestive System Diseases · Colonic Diseases
Primary: Sensitivity and Specificity of the Exact CRC Screening Test With Comparison to Colonoscopy, Both With Respect to Cancer. — 92.3; 73.8; 93.3; 73.3 percent
Colorectal Cancer
Primary: Use of FOBT ColoCARE Home Kit — 14; 2; 14; 0 participants
Colorectal Cancer
Primary: FIT Completion — 10.4; 13.9 Model based percentage of participants — p=.05
Cancer Screening Tests
Primary: Number of Participants Who Completed Colorectal Cancer Screening — 110; 95; 113; 113 Participants
Colon Cancer
Primary: Assess Colorectal Cancer Screening Completion — 305; 130 Participants
Colorectal Carcinoma
Primary: Likelihood of Any Colorectal Cancer (CRC) Screening (for Study-eligible Patients) — 11.8; 4.5 Percentage of participants
Colorectal Cancer
Primary: FIT Completion Among Patients Offered Any Incentive vs. Outreach Alone Each Year — 2391; 738; 1255; 394 Participants — p=0.59
Colorectal Cancer Screening
Primary: Facilitators and Barriers to Implementing Decision Aids, Provider Notifications, and Personal Risk Calculation Using an Electronic Health Record (EHR) to Promote…
Colorectal Cancer · Adenomatous Polyp of Colon · Polyps
Primary: Ct Value (Ct Values From PCR Reaction) — 38.4; 44.3; 44.6 Ct
Colorectal Neoplasms
Primary: Colorectal Cancer (CRC) Screening Rate. — 40.1; 40.2; 19.3 percentage of participants
Colorectal Cancer
Primary: Concordance Between Patient Preference and Test Ordered — 148; 147 Participants — p=0.40
Colorectal Cancer
Primary: CRC Screening Completion Rates — 550; 751 Participants — p=0.05
Colorectal Cancer
Primary: Percentage of Participants Who Undergo Screening Within 6 Months of Outreach — 17; 31 Participants
Colorectal Neoplasms
Primary: Completion of a Fecal Occult Blood Test (FOBT) — 185; 84 participants
Colorectal Cancer
Primary: Participants Completing CRC Screening Per Electronic Medical Record Documentation — 37; 59; 27 Participants
Colorectal Cancer
Primary: Number of Participants With Advanced Adenomas (>=10mm) as Determined by Colonoscopy (Per Patient) — 109; 2422 Participants
Colon Cancer · Rectal Cancer · Colon Neoplasm
Primary: Sensitivity for Colorectal Cancer — 79.2 Percent
Colorectal Cancer
Primary: Specificity of the Multi-target Stool DNA Test in Average Risk Population, Ages 45-49 — 95.3 percentage of participants
Colorectal Cancer
Primary: Initial CRC Screening — 213; 205 Participants — p=0.61
Colorectal Cancer
Primary: Overall Screening Adherence — 88; 153; 115; 44 Participants — p=<0.001
Colorectal Cancer
Primary: CRC Screening Rate — 8611; 3989; 9438; 3186 Participants
Colorectal Cancer Screening
Primary: Number of Participants With an Actionable Lesion on CCE vs. CTC Confirmed by Optical Colonoscopy — 34; 11 Participants
Colorectal Cancer
Primary: Colorectal Cancer Screening by Study Arm — 205; 165; 32 Participants — p=0.04
Colorectal Cancer
Primary: Colorectal Cancer (CRC) Screening Completion — 17; 69 participants — p=0.32
Colorectal Cancer · Advanced Adenocarcinoma · Serrated Polyp
Primary: ColoSense Sensitivity for Colorectal Cancer (CRC) — 25; 2 Participants